An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s ...

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...

Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?

Some health experts view GLP-1s as a promising option for PCOS, which lacks a standard treatment and affects millions of ...

Additionally, new board members were brought in to oversee leadership. Among the appointments were Mike Mason, former president of Eli Lilly's diabetes and obesity business. Existing directors Tara ...

The best-financed lobbyists in the United States are protecting the pharmaceutical sector, but that may change ...

Proposals by Robert F. Kennedy Jr. and Bernie Sanders range from more disclosures in commercials to an outright ban.

In advance of CMS’ negotiated price for the blood thinner taking effect next year, partners Bristol Myers Squibb and Pfizer ...

If every pharma company had this, they would have much greater access to their medications without people in the middle." In ...

By 2023, the tone had shifted. Venture capital cooled. According to CB Insights, funding for AI drug discovery start-ups ...

Trump confirms August 1 start for steep tariffs on copper, pharmaceuticals, and BRICS nations. No more extensions as trade ...

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Jazz Board of Directors has unanimously selected Renee Gala, Jazz's ...